To our knowledge, TREM2 has not been evaluated in pancreatic cancer, but has been shown to play an immunosuppressive role in other tumor types (Katzenelenbogen et al, 2020; Molgora et al, 2020). Here, TREM2 is linked to familial pancreatic carcinoma.